Splenic Injury Following Endoscopic Retrograde Cholangiopancreatography – A Role for Angioembolization by Divyansh Agarwal, Philicia Moonsamy, Carlos Fernandez-Del Castillo

Get full text

Extracellular vesicle analysis of plasma allows differential diagnosis of atypical pancreatic serous cystadenoma by Katherine S. Yang, Aileen O’Shea, Piotr Zelga, Andrew S. Liss, Carlos Fernandez Del Castillo, Ralph Weissleder

Get full text

Pancreatic duct glands (PDGs) are a progenitor compartment responsible for pancreatic ductal epithelial repair by Junpei Yamaguchi, Andrew S. Liss, Alexandra Sontheimer, Mari Mino-Kenudson, Carlos Fernández-del Castillo, Andrew L. Warshaw, Sarah P. Thayer

Get full text

The value of KRAS mutation testing with CEA for the diagnosis of pancreatic mucinous cysts by Abdurrahman Kadayifci, Mohammad Al-Haddad, Mustafa Atar, John M. Dewitt, David G. Forcione, Stuart Sherman, Brenna W. Casey, Carlos Fernandez-del Castillo, C. Max Schmidt, Martha B. Pitman, William R. Brugge

Get full text

Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival. by Ilaria Pergolini, Vicente Morales-Oyarvide, Mari Mino-Kenudson, Kim C Honselmann, Matthew W Rosenbaum, Sabikun Nahar, Marina Kem, Cristina R Ferrone, Keith D Lillemoe, Nabeel Bardeesy, David P Ryan, Sarah P Thayer, Andrew L Warshaw, Carlos Fernández-Del Castillo, Andrew S Liss

Get full text

Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target by Joseph W. Franses, Julia Philipp, Pavlos Missios, Irun Bhan, Ann Liu, Chittampalli Yashaswini, Eric Tai, Huili Zhu, Matteo Ligorio, Benjamin Nicholson, Elizabeth M. Tassoni, Niyati Desai, Anupriya S. Kulkarni, Annamaria Szabolcs, Theodore S. Hong, Andrew S. Liss, Carlos Fernandez-del Castillo, David P. Ryan, Shyamala Maheswaran, Daniel A. Haber, George Q. Daley, David T. Ting

Get full text

Response to Commentary on ‘“Long-Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multi... by Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the Pancreatic Neuroendocrine Disease Alliance (PANDA)

Get full text

Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer—A Cross-Validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of t... by Louisa Bolm, Sergii Zemskov, Maria Zeller, Taisuke Baba, Jorge Roldan, Jon M. Harrison, Natalie Petruch, Hiroki Sato, Ekaterina Petrova, Hryhoriy Lapshyn, Ruediger Braun, Kim C. Honselmann, Richard Hummel, Oleksii Dronov, Alexander V. Kirichenko, Monika Klinkhammer-Schalke, Kees Kleihues-van Tol, Sylke R. Zeissig, Dirk Rades, Tobias Keck, Carlos Fernandez-del Castillo, Ulrich F. Wellner, Rodney E. Wegner

Get full text

Response to Commentary “Are Parenchyma-Sparing Resections Really Appropriate for Small (<3 cm) Non-Functional Pancreatic Neuroendocrine Tumors?” by Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, MD, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the PAncreatic Neuroendocrine Disease Alliance (PANDA)

Get full text